ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutrition and Metabolism
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1688095
The Association Between Magnesium Levels and Gout: Evidence from Mendelian Randomization, a Chinese Cross-Sectional Study, and NHANES Analysis
Provisionally accepted- 1Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China
- 2Department of Rehabilitation Medicine, The First Hospital of China Medical University, Shenyang, China
- 3Department of Nephrology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China
- 4Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Although the roles of micronutrients in human health are widely acknowledged, their specific associations with gout remain inadequately explored. This study integrates evidence from Mendelian randomization (MR), Chinese cross-sectional, and NHANES analyses to comprehensively investigate. First, the MR analysis was used to evaluate the potential causal associations between 15 trace elements (copper, calcium, iron, magnesium, potassium, selenium, zinc, carotenoids, folate, vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, and vitamin E) and gout risk from the FinnGen database (n = 327,457). Calcium, magnesium, and vitamin B6 were screened out (Inverse Variance Weighted: P < 0.05). Multivariable MR indicated that higher magnesium reduced gout risk (OR = 0.630, 95% CI: 0.400 - 0.992, P = 0.046). Subsequently, logistic regression analysis of Chinese clinical data (n = 4,359) supported that high serum magnesium levels (Q4) were associated with lower gout risk (OR = 0.546, 95% CI: 0.319–0.933, P = 0.027) than the lowest magnesium levels (Q1). Finally, the NHANES (2011-2018, n = 13,902) analysis indicated that higher dietary magnesium intake was associated with lower gout risk (OR = 0.738, 95% CI: 0.550– 0.989, P = 0.049). Additionally, the restricted cubic spline (RCS) found that the OR began below 1 when the dietary magnesium intake exceeded 0.27 g/day. This multifaceted study provides novel evidence supporting a protective role of magnesium against gout. The underlying mechanism may involve magnesium's influence on uric acid or its anti-inflammatory effects. These hypotheses need to be clarified by further experimental and clinical studies.
Keywords: Gout, Magnesium, Mendelian randomization, Cross-sectional study, NHANES
Received: 18 Aug 2025; Accepted: 20 Oct 2025.
Copyright: © 2025 Jiao, Shao, Zhao, Feng, Cui, Luan, Hao, Ma, Feng, Yang and Hua. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Haoshen Feng, ykwqywnwq@126.com
Xu Yang, yangxu7518@126.com
Zhou Hua, huazhou_cmu@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.